HealthInvest Partners AB »

Autolus Therapeutics Plc spon ads shares owned by HealthInvest Partners AB

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by HealthInvest Partners AB from 13F filings

Historical chart of HealthInvest Partners AB investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by HealthInvest Partners AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $615k 96k 6.38
2023-12-31 $621k 96k 6.44

More positions owned by HealthInvest Partners AB

Merck & Co (MRK)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Neurocrine Biosciences (NBIX)
Harmony Biosciences Hldgs In (HRMY)
Stryker Corporation (SYK)
Amgen (AMGN)
Abbvie (ABBV)
Boston Scientific Corporation (BSX)
Regeneron Pharmaceuticals (REGN)
AmerisourceBergen (COR)
Molina Healthcare (MOH)
Vertex Pharmaceuticals Incorporated (VRTX)
Option Care Health Com New (OPCH)

View all positions for HealthInvest Partners AB

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads